These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2882308)

  • 1. Myelosuppression after methotrexate, mitozantrone, and mitomycin C for treatment of advanced breast cancer.
    Marks A; Goodman A; Dougherty S; Ashford R
    Lancet; 1987 Apr; 1(8538):915. PubMed ID: 2882308
    [No Abstract]   [Full Text] [Related]  

  • 2. Myelosuppression after methotrexate, mitoxantrone, and mitomycin C.
    Jodrell DI; Iveson TJ; Smith IE
    Lancet; 1987 May; 1(8543):1211. PubMed ID: 2883528
    [No Abstract]   [Full Text] [Related]  

  • 3. Myelotoxicity of methotrexate, mitozantrone, and mitomycin C.
    Morton AR; Anderson H; Howell A
    Lancet; 1987 Jun; 1(8548):1494. PubMed ID: 2885486
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer.
    Jodrell DI; Smith IE; Mansi JL; Pearson MC; Walsh G; Ashley S; Sinnett HD; McKinna JA
    Br J Cancer; 1991 May; 63(5):794-8. PubMed ID: 2039705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer.
    Powles TJ; Jones AL; Judson IR; Hardy JR; Ashley SE
    Br J Cancer; 1991 Aug; 64(2):406-10. PubMed ID: 1892775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelosuppression after methotrexate, mitozantrone, and mitomycin C combination chemotherapy.
    Powles TI; Ashley S
    Lancet; 1987 Oct; 2(8563):853. PubMed ID: 2889049
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute myeloid leukemia following 3M (mitoxantrone, mitomycin and methotrexate) chemotherapy for advanced breast cancer.
    Melillo LM; Sajeva MR; Musto P; Perla G; Cascavilla N; Minervini MM; D'Arena G; Carotenuto M
    Leukemia; 1997 Dec; 11(12):2211-3. PubMed ID: 9447844
    [No Abstract]   [Full Text] [Related]  

  • 8. Unexpected prolonged myelosuppression after mitomycin, mitoxantrone and methotrexate.
    Muhonen TT; Wiklund TA; Blomqvist CP; Pyrhönen SO
    Eur J Cancer; 1992; 28A(12):1974-6. PubMed ID: 1419293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose intensification of chemotherapy in advanced breast cancer: a feasibility phase II study.
    Pedrazzoli P; Zamagni C; Martoni A; Capotorto AM; Da Prada GA; Pavesi L; Preti P; Lelli G; Pannuti F; Robustelli della Cuna G
    Tumori; 1994 Aug; 80(4):273-5. PubMed ID: 7526508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of mitozantrone, methotrexate and mitomycin with granulocyte colony-stimulating factor (filgrastim) in patients with advanced breast cancer.
    O'Brien ME; Nicolson M; Montes A; Tidy A; Ashley S; Powles TJ
    Br J Cancer; 1994 Nov; 70(5):980-3. PubMed ID: 7524607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitozantrone and methotrexate chemotherapy with and without mitomycin C in the treatment of advanced breast cancer: a randomised clinical trial.
    Stein RC; Bower M; Law M; Bliss JM; Barton C; Gazet JC; Ford HT; Coombes RC
    Eur J Cancer; 1992; 28A(12):1963-5. PubMed ID: 1419290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitomycin C and mitoxantrone chemotherapy for advanced breast cancer: efficacy with minimal gastrointestinal toxicity and alopecia.
    Panasci L; Shenouda G; Begin L; Pollak M; Reinke A; Margolese R
    Cancer Chemother Pharmacol; 1990; 26(6):457-60. PubMed ID: 2121379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
    Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
    J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin C, melphalan and methotrexate combination chemotherapy for palliation of disseminated breast cancer.
    Perez DJ; Powles TJ; Gazet JC; Ford HT; Coombes RC
    Cancer Chemother Pharmacol; 1984; 13(1):36-8. PubMed ID: 6203662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage chemotherapy with mitoxantrone and mitomycin with or without methotrexate in advanced breast cancer.
    Astone A; Cassano A; Fontana T; Noviello MR; Pozzo C; Barone C
    Anticancer Drugs; 1992 Oct; 3(5):471-3. PubMed ID: 1450440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelodysplastic syndrome as a complication of neo-adjuvant triple M chemotherapy and radiotherapy.
    Partridge SE; Lowdell CP
    Clin Oncol (R Coll Radiol); 1999; 11(3):187-9. PubMed ID: 10465474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prolonged remissions induced by the combination vindesine, mitoxantrone, mitomycine C in metastatic breast cancers].
    Belpomme D; Cour V; Gisselbrecht C; Le Rol A; Mignot L; Marty M; Godeffroy W; Maral J
    Presse Med; 1987 Apr; 16(13):635. PubMed ID: 2952982
    [No Abstract]   [Full Text] [Related]  

  • 18. High risk of therapy-related leukemia and preleukemia after therapy with prednimustine, methotrexate, 5-fluorouracil, mitoxantrone, and tamoxifen for advanced breast cancer.
    Andersson M; Philip P; Pedersen-Bjergaard J
    Cancer; 1990 Jun; 65(11):2460-4. PubMed ID: 2337861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumonitis complicating selective intra-arterial chemotherapy for locally advanced breast carcinoma.
    McLean AD; Doughty JC; Reid AW; McCarter DH; Kane E; McArdle CS
    Postgrad Med J; 1996 Feb; 72(844):117-8. PubMed ID: 8871465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelodysplasia and acute myeloid leukaemia following adjuvant chemotherapy for breast cancer using mitoxantrone and methotrexate with or without mitomycin.
    Cremin P; Flattery M; McCann SR; Daly PA
    Ann Oncol; 1996 Sep; 7(7):745-6. PubMed ID: 8905034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.